Periodic Report 2 - SETTREND (Schistosoma epigenetics - targets, regulation, new drugs)
Project ID: 241865Funded under: FP7-HEALTH
This is the periodic Report for the SETTREND project which received funding under the European Commission's Seventh Framework Programme (FP7). SEETREND's overall aim was to develop new drug leads for the treatment of schistosomiasis. For this purpose, it sought to develop novel inhibitors for histone modifying enzymes (HMEs). The report explains the project context and refers to its main objectives. It then lists the work performed during the first and the second half of the project. The last part covers the expected final results and their potential impact.
Download application/zip (281213)
Record Number: 16090 / Last updated on: 2011-04-14